Global Onychomycosis (Tinea Unguium) Drug Market Insights and Forecast to 2028

Report ID: 1542334 | Published Date: Jan 2025 | No. of Page: 118 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Oral Medication
        1.2.3 External Medicine
    1.3 Market by Application
        1.3.1 Global Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Age under 18
        1.3.3 Age 18-50
        1.3.4 Age above 50
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Onychomycosis (Tinea Unguium) Drug Market Perspective (2017-2028)
    2.2 Onychomycosis (Tinea Unguium) Drug Growth Trends by Region
        2.2.1 Onychomycosis (Tinea Unguium) Drug Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Onychomycosis (Tinea Unguium) Drug Historic Market Size by Region (2017-2022)
        2.2.3 Onychomycosis (Tinea Unguium) Drug Forecasted Market Size by Region (2023-2028)
    2.3 Onychomycosis (Tinea Unguium) Drug Market Dynamics
        2.3.1 Onychomycosis (Tinea Unguium) Drug Industry Trends
        2.3.2 Onychomycosis (Tinea Unguium) Drug Market Drivers
        2.3.3 Onychomycosis (Tinea Unguium) Drug Market Challenges
        2.3.4 Onychomycosis (Tinea Unguium) Drug Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Onychomycosis (Tinea Unguium) Drug Players by Revenue
        3.1.1 Global Top Onychomycosis (Tinea Unguium) Drug Players by Revenue (2017-2022)
        3.1.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Players (2017-2022)
    3.2 Global Onychomycosis (Tinea Unguium) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Onychomycosis (Tinea Unguium) Drug Revenue
    3.4 Global Onychomycosis (Tinea Unguium) Drug Market Concentration Ratio
        3.4.1 Global Onychomycosis (Tinea Unguium) Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Onychomycosis (Tinea Unguium) Drug Revenue in 2021
    3.5 Onychomycosis (Tinea Unguium) Drug Key Players Head office and Area Served
    3.6 Key Players Onychomycosis (Tinea Unguium) Drug Product Solution and Service
    3.7 Date of Enter into Onychomycosis (Tinea Unguium) Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Onychomycosis (Tinea Unguium) Drug Breakdown Data by Type
    4.1 Global Onychomycosis (Tinea Unguium) Drug Historic Market Size by Type (2017-2022)
    4.2 Global Onychomycosis (Tinea Unguium) Drug Forecasted Market Size by Type (2023-2028)
5 Onychomycosis (Tinea Unguium) Drug Breakdown Data by Application
    5.1 Global Onychomycosis (Tinea Unguium) Drug Historic Market Size by Application (2017-2022)
    5.2 Global Onychomycosis (Tinea Unguium) Drug Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Onychomycosis (Tinea Unguium) Drug Market Size (2017-2028)
    6.2 North America Onychomycosis (Tinea Unguium) Drug Market Size by Type
        6.2.1 North America Onychomycosis (Tinea Unguium) Drug Market Size by Type (2017-2022)
        6.2.2 North America Onychomycosis (Tinea Unguium) Drug Market Size by Type (2023-2028)
        6.2.3 North America Onychomycosis (Tinea Unguium) Drug Market Share by Type (2017-2028)
    6.3 North America Onychomycosis (Tinea Unguium) Drug Market Size by Application
        6.3.1 North America Onychomycosis (Tinea Unguium) Drug Market Size by Application (2017-2022)
        6.3.2 North America Onychomycosis (Tinea Unguium) Drug Market Size by Application (2023-2028)
        6.3.3 North America Onychomycosis (Tinea Unguium) Drug Market Share by Application (2017-2028)
    6.4 North America Onychomycosis (Tinea Unguium) Drug Market Size by Country
        6.4.1 North America Onychomycosis (Tinea Unguium) Drug Market Size by Country (2017-2022)
        6.4.2 North America Onychomycosis (Tinea Unguium) Drug Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Onychomycosis (Tinea Unguium) Drug Market Size (2017-2028)
    7.2 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Type
        7.2.1 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Type (2017-2022)
        7.2.2 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Type (2023-2028)
        7.2.3 Europe Onychomycosis (Tinea Unguium) Drug Market Share by Type (2017-2028)
    7.3 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Application
        7.3.1 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Application (2017-2022)
        7.3.2 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Application (2023-2028)
        7.3.3 Europe Onychomycosis (Tinea Unguium) Drug Market Share by Application (2017-2028)
    7.4 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country
        7.4.1 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country (2017-2022)
        7.4.2 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size (2017-2028)
    8.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Type
        8.2.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Share by Type (2017-2028)
    8.3 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Application
        8.3.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Share by Application (2017-2028)
    8.4 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Region
        8.4.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Onychomycosis (Tinea Unguium) Drug Market Size (2017-2028)
    9.2 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Type
        9.2.1 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Type (2017-2022)
        9.2.2 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Type (2023-2028)
        9.2.3 Latin America Onychomycosis (Tinea Unguium) Drug Market Share by Type (2017-2028)
    9.3 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Application
        9.3.1 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Application (2017-2022)
        9.3.2 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Application (2023-2028)
        9.3.3 Latin America Onychomycosis (Tinea Unguium) Drug Market Share by Application (2017-2028)
    9.4 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Country
        9.4.1 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Country (2017-2022)
        9.4.2 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size (2017-2028)
    10.2 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Type
        10.2.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Share by Type (2017-2028)
    10.3 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Application
        10.3.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Share by Application (2017-2028)
    10.4 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Country
        10.4.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Onychomycosis (Tinea Unguium) Drug Introduction
        11.1.4 Pfizer Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
        11.1.5 Pfizer Recent Developments
    11.2 Yangtze River
        11.2.1 Yangtze River Company Details
        11.2.2 Yangtze River Business Overview
        11.2.3 Yangtze River Onychomycosis (Tinea Unguium) Drug Introduction
        11.2.4 Yangtze River Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
        11.2.5 Yangtze River Recent Developments
    11.3 Torrent Pharma
        11.3.1 Torrent Pharma Company Details
        11.3.2 Torrent Pharma Business Overview
        11.3.3 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Introduction
        11.3.4 Torrent Pharma Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
        11.3.5 Torrent Pharma Recent Developments
    11.4 J&J
        11.4.1 J&J Company Details
        11.4.2 J&J Business Overview
        11.4.3 J&J Onychomycosis (Tinea Unguium) Drug Introduction
        11.4.4 J&J Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
        11.4.5 J&J Recent Developments
    11.5 Chengdu Brilliant
        11.5.1 Chengdu Brilliant Company Details
        11.5.2 Chengdu Brilliant Business Overview
        11.5.3 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Introduction
        11.5.4 Chengdu Brilliant Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
        11.5.5 Chengdu Brilliant Recent Developments
    11.6 Novartis
        11.6.1 Novartis Company Details
        11.6.2 Novartis Business Overview
        11.6.3 Novartis Onychomycosis (Tinea Unguium) Drug Introduction
        11.6.4 Novartis Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
        11.6.5 Novartis Recent Developments
    11.7 Qilu Pharmaceutical
        11.7.1 Qilu Pharmaceutical Company Details
        11.7.2 Qilu Pharmaceutical Business Overview
        11.7.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Introduction
        11.7.4 Qilu Pharmaceutical Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
        11.7.5 Qilu Pharmaceutical Recent Developments
    11.8 Xiuzheng Pharmaceutical
        11.8.1 Xiuzheng Pharmaceutical Company Details
        11.8.2 Xiuzheng Pharmaceutical Business Overview
        11.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Introduction
        11.8.4 Xiuzheng Pharmaceutical Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
        11.8.5 Xiuzheng Pharmaceutical Recent Developments
    11.9 Hubei Hengan
        11.9.1 Hubei Hengan Company Details
        11.9.2 Hubei Hengan Business Overview
        11.9.3 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Introduction
        11.9.4 Hubei Hengan Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
        11.9.5 Hubei Hengan Recent Developments
    11.10 TARO
        11.10.1 TARO Company Details
        11.10.2 TARO Business Overview
        11.10.3 TARO Onychomycosis (Tinea Unguium) Drug Introduction
        11.10.4 TARO Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
        11.10.5 TARO Recent Developments
    11.11 Perrigo
        11.11.1 Perrigo Company Details
        11.11.2 Perrigo Business Overview
        11.11.3 Perrigo Onychomycosis (Tinea Unguium) Drug Introduction
        11.11.4 Perrigo Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
        11.11.5 Perrigo Recent Developments
    11.12 Galderma pharm
        11.12.1 Galderma pharm Company Details
        11.12.2 Galderma pharm Business Overview
        11.12.3 Galderma pharm Onychomycosis (Tinea Unguium) Drug Introduction
        11.12.4 Galderma pharm Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
        11.12.5 Galderma pharm Recent Developments
    11.13 Zhejiang Deyer
        11.13.1 Zhejiang Deyer Company Details
        11.13.2 Zhejiang Deyer Business Overview
        11.13.3 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Introduction
        11.13.4 Zhejiang Deyer Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
        11.13.5 Zhejiang Deyer Recent Developments
    11.14 Valeant Pharma
        11.14.1 Valeant Pharma Company Details
        11.14.2 Valeant Pharma Business Overview
        11.14.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Introduction
        11.14.4 Valeant Pharma Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
        11.14.5 Valeant Pharma Recent Developments
    11.15 Moberg
        11.15.1 Moberg Company Details
        11.15.2 Moberg Business Overview
        11.15.3 Moberg Onychomycosis (Tinea Unguium) Drug Introduction
        11.15.4 Moberg Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
        11.15.5 Moberg Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Oral Medication
    Table 3. Key Players of External Medicine
    Table 4. Global Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Onychomycosis (Tinea Unguium) Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Onychomycosis (Tinea Unguium) Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Onychomycosis (Tinea Unguium) Drug Market Share by Region (2017-2022)
    Table 8. Global Onychomycosis (Tinea Unguium) Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Onychomycosis (Tinea Unguium) Drug Market Share by Region (2023-2028)
    Table 10. Onychomycosis (Tinea Unguium) Drug Market Trends
    Table 11. Onychomycosis (Tinea Unguium) Drug Market Drivers
    Table 12. Onychomycosis (Tinea Unguium) Drug Market Challenges
    Table 13. Onychomycosis (Tinea Unguium) Drug Market Restraints
    Table 14. Global Onychomycosis (Tinea Unguium) Drug Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Players (2017-2022)
    Table 16. Global Top Onychomycosis (Tinea Unguium) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Onychomycosis (Tinea Unguium) Drug as of 2021)
    Table 17. Ranking of Global Top Onychomycosis (Tinea Unguium) Drug Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Onychomycosis (Tinea Unguium) Drug Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Onychomycosis (Tinea Unguium) Drug Product Solution and Service
    Table 21. Date of Enter into Onychomycosis (Tinea Unguium) Drug Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Onychomycosis (Tinea Unguium) Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Type (2017-2022)
    Table 25. Global Onychomycosis (Tinea Unguium) Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Type (2023-2028)
    Table 27. Global Onychomycosis (Tinea Unguium) Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Application (2017-2022)
    Table 29. Global Onychomycosis (Tinea Unguium) Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Application (2023-2028)
    Table 31. North America Onychomycosis (Tinea Unguium) Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Onychomycosis (Tinea Unguium) Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Onychomycosis (Tinea Unguium) Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Onychomycosis (Tinea Unguium) Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Onychomycosis (Tinea Unguium) Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Onychomycosis (Tinea Unguium) Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Onychomycosis (Tinea Unguium) Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Onychomycosis (Tinea Unguium) Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Onychomycosis (Tinea Unguium) Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Onychomycosis (Tinea Unguium) Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Pfizer Company Details
    Table 62. Pfizer Business Overview
    Table 63. Pfizer Onychomycosis (Tinea Unguium) Drug Product
    Table 64. Pfizer Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022) & (US$ Million)
    Table 65. Pfizer Recent Developments
    Table 66. Yangtze River Company Details
    Table 67. Yangtze River Business Overview
    Table 68. Yangtze River Onychomycosis (Tinea Unguium) Drug Product
    Table 69. Yangtze River Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022) & (US$ Million)
    Table 70. Yangtze River Recent Developments
    Table 71. Torrent Pharma Company Details
    Table 72. Torrent Pharma Business Overview
    Table 73. Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product
    Table 74. Torrent Pharma Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022) & (US$ Million)
    Table 75. Torrent Pharma Recent Developments
    Table 76. J&J Company Details
    Table 77. J&J Business Overview
    Table 78. J&J Onychomycosis (Tinea Unguium) Drug Product
    Table 79. J&J Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022) & (US$ Million)
    Table 80. J&J Recent Developments
    Table 81. Chengdu Brilliant Company Details
    Table 82. Chengdu Brilliant Business Overview
    Table 83. Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product
    Table 84. Chengdu Brilliant Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022) & (US$ Million)
    Table 85. Chengdu Brilliant Recent Developments
    Table 86. Novartis Company Details
    Table 87. Novartis Business Overview
    Table 88. Novartis Onychomycosis (Tinea Unguium) Drug Product
    Table 89. Novartis Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022) & (US$ Million)
    Table 90. Novartis Recent Developments
    Table 91. Qilu Pharmaceutical Company Details
    Table 92. Qilu Pharmaceutical Business Overview
    Table 93. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product
    Table 94. Qilu Pharmaceutical Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022) & (US$ Million)
    Table 95. Qilu Pharmaceutical Recent Developments
    Table 96. Xiuzheng Pharmaceutical Company Details
    Table 97. Xiuzheng Pharmaceutical Business Overview
    Table 98. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product
    Table 99. Xiuzheng Pharmaceutical Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022) & (US$ Million)
    Table 100. Xiuzheng Pharmaceutical Recent Developments
    Table 101. Hubei Hengan Company Details
    Table 102. Hubei Hengan Business Overview
    Table 103. Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product
    Table 104. Hubei Hengan Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022) & (US$ Million)
    Table 105. Hubei Hengan Recent Developments
    Table 106. TARO Company Details
    Table 107. TARO Business Overview
    Table 108. TARO Onychomycosis (Tinea Unguium) Drug Product
    Table 109. TARO Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022) & (US$ Million)
    Table 110. TARO Recent Developments
    Table 111. Perrigo Company Details
    Table 112. Perrigo Business Overview
    Table 113. Perrigo Onychomycosis (Tinea Unguium) Drug Product
    Table 114. Perrigo Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022) & (US$ Million)
    Table 115. Perrigo Recent Developments
    Table 116. Galderma pharm Company Details
    Table 117. Galderma pharm Business Overview
    Table 118. Galderma pharm Onychomycosis (Tinea Unguium) Drug Product
    Table 119. Galderma pharm Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022) & (US$ Million)
    Table 120. Galderma pharm Recent Developments
    Table 121. Zhejiang Deyer Company Details
    Table 122. Zhejiang Deyer Business Overview
    Table 123. Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product
    Table 124. Zhejiang Deyer Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022) & (US$ Million)
    Table 125. Zhejiang Deyer Recent Developments
    Table 126. Valeant Pharma Company Details
    Table 127. Valeant Pharma Business Overview
    Table 128. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product
    Table 129. Valeant Pharma Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022) & (US$ Million)
    Table 130. Valeant Pharma Recent Developments
    Table 131. Moberg Company Details
    Table 132. Moberg Business Overview
    Table 133. Moberg Onychomycosis (Tinea Unguium) Drug Product
    Table 134. Moberg Revenue in Onychomycosis (Tinea Unguium) Drug Business (2017-2022) & (US$ Million)
    Table 135. Moberg Recent Developments
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Onychomycosis (Tinea Unguium) Drug Market Share by Type: 2021 VS 2028
    Figure 2. Oral Medication Features
    Figure 3. External Medicine Features
    Figure 4. Global Onychomycosis (Tinea Unguium) Drug Market Share by Application: 2021 VS 2028
    Figure 5. Age under 18 Case Studies
    Figure 6. Age 18-50 Case Studies
    Figure 7. Age above 50 Case Studies
    Figure 8. Onychomycosis (Tinea Unguium) Drug Report Years Considered
    Figure 9. Global Onychomycosis (Tinea Unguium) Drug Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Onychomycosis (Tinea Unguium) Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Onychomycosis (Tinea Unguium) Drug Market Share by Region: 2021 VS 2028
    Figure 12. Global Onychomycosis (Tinea Unguium) Drug Market Share by Players in 2021
    Figure 13. Global Top Onychomycosis (Tinea Unguium) Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Onychomycosis (Tinea Unguium) Drug as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Onychomycosis (Tinea Unguium) Drug Revenue in 2021
    Figure 15. North America Onychomycosis (Tinea Unguium) Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type (2017-2028)
    Figure 17. North America Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application (2017-2028)
    Figure 18. North America Onychomycosis (Tinea Unguium) Drug Market Size Share by Country (2017-2028)
    Figure 19. United States Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Onychomycosis (Tinea Unguium) Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Onychomycosis (Tinea Unguium) Drug Market Size Share by Country (2017-2028)
    Figure 25. Germany Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size Share by Region (2017-2028)
    Figure 35. China Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Onychomycosis (Tinea Unguium) Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Onychomycosis (Tinea Unguium) Drug Market Size Share by Country (2017-2028)
    Figure 45. Mexico Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size Share by Country (2017-2028)
    Figure 51. Turkey Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Onychomycosis (Tinea Unguium) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Pfizer Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
    Figure 55. Yangtze River Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
    Figure 56. Torrent Pharma Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
    Figure 57. J&J Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
    Figure 58. Chengdu Brilliant Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
    Figure 59. Novartis Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
    Figure 60. Qilu Pharmaceutical Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
    Figure 61. Xiuzheng Pharmaceutical Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
    Figure 62. Hubei Hengan Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
    Figure 63. TARO Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
    Figure 64. Perrigo Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
    Figure 65. Galderma pharm Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
    Figure 66. Zhejiang Deyer Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
    Figure 67. Valeant Pharma Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
    Figure 68. Moberg Revenue Growth Rate in Onychomycosis (Tinea Unguium) Drug Business (2017-2022)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Yangtze River
Torrent Pharma
J&J
Chengdu Brilliant
Novartis
Qilu Pharmaceutical
Xiuzheng Pharmaceutical
Hubei Hengan
TARO
Perrigo
Galderma pharm
Zhejiang Deyer
Valeant Pharma
Moberg
Frequently Asked Questions
Onychomycosis (Tinea Unguium) Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Onychomycosis (Tinea Unguium) Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Onychomycosis (Tinea Unguium) Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Opthalmic Lenses

Opthalmic Lenses market is segmented by Type and by Application. Players, stakeholders, and other ... Read More

Milk Powder

Milk Powder market is segmented by Type and by Application. Players, stakeholders, and other part ... Read More

Ornamental Fish Feed

Ornamental Fish Feed market is segmented by Type and by Application. Players, stakeholders, and o ... Read More